Security key
09075P204
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)
CUSIP: 09075P204
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 21,847,524
- Total 13F shares
- 5,439,683
- Share change
- +1,904,089
- Total reported value
- $7,274,423
- Price per share
- $1.34
- Number of holders
- 39
- Value change
- +$2,473,613
- Number of buys
- 13
- Number of sells
- 15
Report period
Q1 2026
Institutions
39
Top holders
10
BTAI full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
BioXcel Therapeutics, Inc. SEC filings
BioXcel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09075P204
Recent filing periods:
Ownership snapshot
Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
INTEGRATED CORE STRATEGIE...
13D/G signal
INTEGRATED CORE STRATEGIE...
Evidence rows
50
Latest as of
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 8.4%
13D/G row: INTEGRATED CORE STRATEGIES (US) LLC
Showing first 8 of 50 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
Millennium Management LLC
|
8.4%
|
$3,762,144
1,835,192 shares
|
+$1,654,635 | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
7%
|
$324,713
1,910,076 shares
|
$0 | 31 Mar 2026 |
| Oaktree Capital Group Holdings GP, LLC |
13D/G
Oaktree Capital Holdings, LLC
|
2.7%
|
$28,939
170,230 shares
|
-$434,154 | 31 Mar 2025 |
| Qatar Investment Authority |
13D/G
|
0.6%
|
$26,531
156,066 shares
|
-$436,562 | 31 Dec 2025 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
8.4%
|
$2,936,307
1,835,192 shares
|
— | 31 Dec 2025 |
| VANGUARD GROUP INC |
13F
Company
|
1.3%
|
$468,405
292,753 shares
|
— | 31 Dec 2025 |
| OAKTREE CAPITAL MANAGEMENT LP |
13F
Company
|
1.1%
|
$385,902
241,188 shares
|
— | 31 Dec 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.94%
|
$329,873
206,168 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
39
Shares
5,439,683
Rows loaded
39
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
42
Q1 2026 holders
39
Holder diff
-3
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend